###begin article-title 0
The orphan Rev-erb nuclear receptors: a link between metabolism, circadian rhythm and inflammation? 
###end article-title 0
###begin p 1
###xml 323 328 <span type="species:ncbi:9606">human</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
###xml 1384 1394 <span type="species:ncbi:7227">Drosophila</span>
###xml 1409 1414 <span type="species:ncbi:9606">human</span>
###xml 1566 1576 <span type="species:ncbi:7227">Drosophila</span>
###xml 1591 1596 <span type="species:ncbi:9606">human</span>
Nuclear hormone receptors (NRs) function as ligand dependent DNA binding proteins that translate physiological/nutritional signals into gene regulation. Dysfunctional NR signaling leads to many disorders in reproduction, inflammation, and metabolism. The opportunity to identify novel regulatory pathways in the context of human health and disease drives the challenge to unravel the biological function of the "orphan nuclear hormone receptors". For example, the Rev-erb (NR1D) subgroup (Rev-erbalpha/NR1D1 and Rev-erbbeta/NR1D2) of orphan NRs are transcriptional silencers and negative regulators of RORalpha mediated trans-activation. The NR1D subgroup is highly enriched in peripheral tissues with onerous energy demands including skeletal muscle, brown and white adipose, brain, liver and kidney. This alludes to the involvement of this subgroup in metabolism. In this context, Rev-erbalpha-/- mice have a dyslipidemic phenotype. Recent studies in vascular smooth and skeletal muscle cells also suggest that the NR1D subgroup modulates inflammation by regulating IkappaBalpha/NFkappaB dependent gene expression. Rev-erbalpha has been identified as a critical regulator (and target) of circadian rhythm, a factor in blood pressure control and inflammation. Finally, two recent reports have demonstrated: (i) lithium mediated regulation of Rev-erbalpha stability and (ii) E75 (the Drosophila orthologue of human Rev-erbalpha) is tightly bound by heme, and functions as a "gas sensor" through interaction with CO/NO and interferes with the repression of DHR3 (the Drosophila orthologue of human RORalpha). In conclusion, the role of these receptors at the cross-roads of metabolism, inflammation, and circadian cycling underscores the importance of understanding the organ-specific function of the NR1D subgroup in homeostasis.
###end p 1
###begin title 2
The NR1D subgroup of orphan NRs, Rev-erbalpha (NR1D1) and Rev-erbbeta (NR1D2)
###end title 2
###begin p 3
###xml 418 441 418 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r70" ref-type="bibr">Gronemeyer et al., 2004</xref>
All members of the NR superfamily display a highly conserved structural organisation with an amino terminal AB region (that encodes activation function 1, AF-1); followed by the C-region which encodes the DNA binding domain (DBD); a linker region D and the C-terminal E region. The DE region encodes the ligand binding domain (LBD), and a transcriptional domain (in helix 12), denoted as activation function 2 (AF-2) [Gronemeyer et al., 2004].
###end p 3
###begin p 4
###xml 69 87 65 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r81" ref-type="bibr">Lazar et al., 1989</xref>
###xml 114 132 107 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r83" ref-type="bibr">Dumas et al., 1994</xref>
###xml 134 157 127 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r82" ref-type="bibr">Retnakaran et al., 1994</xref>
###xml 221 241 214 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r84" ref-type="bibr">Giguere et al., 1994</xref>
###xml 243 268 236 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r47" ref-type="bibr">Laitinen and Staels, 2003</xref>
###xml 364 365 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 682 701 671 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r4" ref-type="bibr">Forman et al., 1994</xref>
###xml 766 787 747 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r76" ref-type="bibr">Delerive et al., 2002</xref>
###xml 789 808 770 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r99" ref-type="bibr">Raspe et al., 2002b</xref>
###xml 861 882 838 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r5" ref-type="bibr">Adelmant et al., 1996</xref>
The Rev-erb/NR1D subgroup contains two members, Rev-erbalpha (NR1D1;[Lazar et al., 1989]) and Rev-erbbeta (NR1D2;[Dumas et al., 1994; Retnakaran et al., 1994]). The Rev-erbs, and retinoid related orphan receptors (RORs; [Giguere et al., 1994; Laitinen and Staels, 2003] bind as monomers to the consensus NR half-site motif, flanked by an 6bp AT-rich sequence (A/T)6 PuGGTCA, or as a homodimer to a direct repeat of the core motif separated by 2 bp. Although these receptors are closely related, and bind to the same motif, they function in an opposing manner. The NR1D subgroup function as dominant transcriptional silencers, and they repress trans-activation mediated by RORalpha [Forman et al., 1994]. Interestingly, RORalpha activates Rev-erbalpha transcription [Delerive et al., 2002; Raspe et al., 2002b], and Rev-erbalpha represses its own transcription [Adelmant et al., 1996].
###end p 4
###begin p 5
###xml 308 327 308 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r77" ref-type="bibr">Renaud et al., 2000</xref>
Homology modeling of the putative LBDs of the NR1D subgroup suggested that the pocket is occupied by bulky side chains, and the small residual cavity could not "accommodate" a classical ligand. Concordantly, NR1D1 and 2 are the only members of the superfamily that do not encode helix 12 and an AF-2 domain [Renaud et al., 2000]. However, the existence of a novel small molecular regulator cannot be precluded. Molecular modeling also revealed a very hydrophobic surface due to the absence of H12, exposing residues from H3, loop 3-4, H4, and H11 that mediate corepressor recruitment.
###end p 5
###begin title 6
Rev-erbs and lipid metabolism
###end title 6
###begin p 7
###xml 84 103 80 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r9" ref-type="bibr">Vu-Dac et al., 1998</xref>
###xml 106 113 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 325 350 314 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r12" ref-type="bibr">Coste and Rodriguez, 2002</xref>
###xml 364 383 353 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r13" ref-type="bibr">Raspe et al., 2002a</xref>
###xml 540 559 525 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r100" ref-type="bibr">Chomez et al., 2000</xref>
###xml 613 632 598 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r13" ref-type="bibr">Raspe et al., 2002a</xref>
###xml 853 878 834 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r47" ref-type="bibr">Laitinen and Staels, 2003</xref>
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 319 323 <span type="species:ncbi:10116">rats</span>
###xml 356 362 <span type="species:ncbi:9606">humans</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
Rev-erbalpha has been shown to be involved in repressing rat apoA1 gene expression [Vu-Dac et al., 1998]. in vivo studies have shown that apoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice. Moreover, human Rev-erbalpha and beta specifically repress apoCIII gene expression in rats [Coste and Rodriguez, 2002] and humans [Raspe et al., 2002a]. ApoCIII is a component of HDL and VLDL that regulates triglyceride levels and lipoprotein lipase activity. In this context Rev-erbalpha null mutant mice [Chomez et al., 2000] have elevated VLDL triglyceride and apoCIII levels [Raspe et al., 2002a]. It is interesting to note that plasma triglyceride and apoC-III protein concentrations in staggerer (sg/sg) mice, homozygous for a deletion in the RORalpha gene, were significantly lower than in wild type littermates [Laitinen and Staels, 2003]. This is in agreement with the repression and activation of apoCIII gene expression by Rev-erbalpha and RORalpha, respectively. Moreover, it highlights the regulatory crosstalk between Rev-erbalpha and RORalpha in the context of the blood lipid profile.
###end p 7
###begin p 8
###xml 83 103 79 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r96" ref-type="bibr">Gervois et al., 1999</xref>
###xml 677 696 642 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r109" ref-type="bibr">Kassam et al., 1999</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 1010 1016 <span type="species:ncbi:9606">humans</span>
###xml 1021 1025 <span type="species:ncbi:10116">rats</span>
###xml 1139 1142 <span type="species:ncbi:10116">rat</span>
###xml 1225 1228 <span type="species:ncbi:10116">rat</span>
###xml 1241 1246 <span type="species:ncbi:9606">human</span>
Hypolipidemic fibrate drugs increase Rev-erbalpha expression in human liver cells [Gervois et al., 1999]. Interestingly, the fibrate mediated activation occurs at the transcriptional level in a PPARalpha dependent manner. The mechanism involves a previously characterized Rev-erbalpha response element; a unique DR2 element whose 5' region is flanked by AT-rich sequence. Rev-erbalpha and PPARalpha compete for binding to this response element in the Rev-erbalpha promoter. Moreover, Rev-erbalpha has been shown to modulate hydratase-dehydrogenase expression, a key gene involved in peroxisomal beta-oxidation pathway through repression of PPARalpha-dependent transactivation [Kassam et al., 1999]. Similarly, the mechanisms involved direct binding to a PPRE, however, the Rev-erbalpha and PPARalpha binding characteristics to the response element were distinct. Furthermore, fibrates regulate apoA1 gene expression in a species specific manner. For example, fibrates increase and decrease apoA1 expression in humans and rats respectively. Firstly, the repression of apoA1 expression in fibrates is due to a 3 nucleotide difference in the rat promoter that produces a non-functional PPARalpha response element. Secondly, the rat but not the human promoter harbors a Rev-erbalpha response element that mediates Rev-erbalpha dependent repression in the presence of fibrates. These studies underscore the crosstalk between Rev-erbalpha and PPARalpha in the control of lipid homeostasis.
###end p 8
###begin p 9
###xml 150 172 143 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r46" ref-type="bibr">Chawla and Lazar, 1993</xref>
###xml 174 189 167 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r118" ref-type="bibr">Fu et al., 2005</xref>
###xml 191 212 184 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r90" ref-type="bibr">Laitinen et al., 2005</xref>
###xml 426 447 407 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r122" ref-type="bibr">Fontaine et al., 2003</xref>
###xml 600 618 574 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r7" ref-type="bibr">Burke et al., 1996</xref>
###xml 620 639 594 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r55" ref-type="bibr">Downes et al., 1995</xref>
Rev-erbalpha and beta are regulated in a biphasic manner during DMI (Dexamethasone/IBMX/Insulin) and rosiglitazone induced adipocyte differentiation [Chawla and Lazar, 1993; Fu et al., 2005; Laitinen et al., 2005]. Rosiglitazone induced adipogenesis involves PPAR-gamma mediated induction of Rev-erbalpha mRNA expression. In agreement, exogenous expression of Rev-erbalpha in 3T3-L1 cells promoted adipogenic differentiation [Fontaine et al., 2003]. In contrast, Rev-erbalpha and beta antagonistically regulate mammalian muscle differentiation and their expression levels decrease during myogenesis [Burke et al., 1996; Downes et al., 1995].
###end p 9
###begin p 10
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 347 367 336 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r116" ref-type="bibr">Pircher et al., 2005</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
In vivo studies in mice suggest that Rev-erbalpha is preferentially expressed in fast-twitch type IIB and intermediate typeIIA fibers. Moreover, in slow twitch (type I) soleus muscle of Rev-erbalpha homozygous and heterozygous null mutant mice, there is a significant increase in the expression of the beta/slow myosin heavy chain (MyHC) isoform [Pircher et al., 2005]. Type IIB fast fibers utilize glycolysis, in contrast, type IIA combine fast twitch glycolytic capacity with aerobic metabolism. Type I fibers are dependent on the aerobic metabolism of fatty acids. The expression of Rev-erbalpha in energy demanding tissues, the fiber specific expression characteristics, and the effect of the null mutation on the muscle phenotype suggest a role in metabolism.
###end p 10
###begin p 11
###xml 289 314 278 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r40" ref-type="bibr">Ramakrishnan et al., 2005</xref>
###xml 515 548 501 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r114" ref-type="bibr">Gonzalez-Cadavid and Bhasin, 2004</xref>
###xml 847 870 833 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r34" ref-type="bibr">McPherron and Lee, 2002</xref>
###xml 961 969 940 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 762 767 <span type="species:ncbi:10090">mouse</span>
In this context, it has been shown that ectopic Rev-erbbetaDeltaE (that lacks the LBD) expression in skeletal muscle cells attenuated the expression of many genes involved in fatty acid/lipid absorption (including FAT/CD36, FABP-3 and -4), and an expected increase in RORalpha expression [Ramakrishnan et al., 2005]. Interestingly, these authors reported a dramatic decrease in the expression of the mRNA encoding myostatin, a TGF-beta family member that plays a crucial role in regulating muscle and adipose mass [Gonzalez-Cadavid and Bhasin, 2004]. Myostatin -/- mice have increased skeletal muscle mass (from muscle hypertrophy and hyperplasia) accompanied by decreased adiposity. McPherron and Lee reported that the introduction of the myostatin mutation in mouse models of obesity and diabetes, suppressed fat accumulation and hyperglycemia [McPherron and Lee, 2002]. The Rev-erbalpha and Rev-erbbeta target genes and tissues are schematically depicted in Figure 1.
###end p 11
###begin title 12
Rev-erbs and circadian rhythm
###end title 12
###begin p 13
###xml 138 146 134 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 149 172 145 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r103" ref-type="bibr">Balsalobre et al., 1998</xref>
###xml 174 192 170 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r102" ref-type="bibr">Torra et al., 2000</xref>
###xml 368 389 360 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r87" ref-type="bibr">Preitner et al., 2002</xref>
###xml 391 415 383 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r65" ref-type="bibr">Triqueneaux et al., 2004</xref>
###xml 590 598 574 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 601 624 585 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r103" ref-type="bibr">Balsalobre et al., 1998</xref>
###xml 626 649 610 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r93" ref-type="bibr">Emery and Reppert, 2004</xref>
###xml 651 668 635 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r91" ref-type="bibr">Sato et al., 2004</xref>
###xml 670 688 654 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r102" ref-type="bibr">Torra et al., 2000</xref>
###xml 1061 1082 1033 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r87" ref-type="bibr">Preitner et al., 2002</xref>
###xml 1207 1228 1175 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r101" ref-type="bibr">Delaunay et al., 2000</xref>
###xml 1355 1379 1319 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r65" ref-type="bibr">Triqueneaux et al., 2004</xref>
###xml 1536 1547 1500 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r86" ref-type="bibr">Giles, 2005</xref>
###xml 1549 1567 1513 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r85" ref-type="bibr">Ikeda et al., 2004</xref>
###xml 1705 1726 1665 1686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r73" ref-type="bibr">Vgontzas et al., 2004</xref>
###xml 1760 1782 1720 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r74" ref-type="bibr">Takahashi et al., 2001</xref>
###xml 1878 1899 1834 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r121" ref-type="bibr">Koyanagi et al., 2006</xref>
###xml 2076 2092 2028 2044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r120" ref-type="bibr">Yin et al., 2006</xref>
###xml 2475 2499 2420 2444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r113" ref-type="bibr">Guillaumond et al., 2005</xref>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 938 942 <span type="species:ncbi:10090">mice</span>
###xml 1196 1205 <span type="species:ncbi:7955">zebrafish</span>
###xml 1608 1614 <span type="species:ncbi:9606">humans</span>
###xml 1802 1806 <span type="species:ncbi:10090">mice</span>
Rev-erbalpha is involved in circadian timing in brain and liver tissue, and regulates BMAL1, and to a lesser extent CLOCK expression (see Figure 2) [Balsalobre et al., 1998; Torra et al., 2000]. Rev-Erbalpha itself is driven directly by the molecular oscillator, it is activated by the BMAL1-CLOCK heterodimer, and repressed by PERIOD1/2 and CRYPTOCHROME1/2 proteins [Preitner et al., 2002; Triqueneaux et al., 2004]. It is interesting to note that Rev-erbalpha and RORalpha opposingly regulate Bmal1 expression and are an integral component of a complex transcriptional feedback loop (see Figure 2) [Balsalobre et al., 1998; Emery and Reppert, 2004; Sato et al., 2004; Torra et al., 2000]. The amplitude of Bmal1, Clock, and Cry1 mRNA oscillations are significantly attenuated in Rev-erbalpha -/- mice. Rev-erbalpha has been shown to influence period length and phase shifting. Schibler and colleagues demonstrated that Rev-erbalpha -/- mice kept under constant darkness and constant light conditions had a shorter period length compared to wild-type animals [Preitner et al., 2002]. Curiously, the maintenance of circadian pacemaker by Rev-erbalpha is also conserved in other organisms such as zebrafish [Delaunay et al., 2000]. Laudet and colleagues have hypothesized that Rev-erbalpha can function as integrator of circadian and physiological events [Triqueneaux et al., 2004]. The literature provides copious examples of circadian regulation of blood pressure, and hypertensive fluctuations associated with cardiovascular disease [Giles, 2005; Ikeda et al., 2004]. Furthermore, aberrant sleep cycles in humans lead to increased secretion of proinflammatory cytokines (for example TNFalpha and IL-6) [Vgontzas et al., 2004] and reduced cortisol secretion [Takahashi et al., 2001]. In this context, mice treated with prednisolone repressed Rev-erbalpha and Bmal1 expression [Koyanagi et al., 2006]. Very recently, Yin et al. demonstrated that glycogen synthase kinase 3 (GSK3)-mediated phosphorylation of Rev-erbalpha and stabilizes the expression of the nuclear receptor [Yin et al., 2006]. Excitingly, they went on to demonstrate that lithium treatment (commonly used to treat bipolar disorder) leads to proteosomal degradation of Rev-erbalpha and induction of Bmal 1. This process is mediated by lithium induced inhibition of GSK3. Finally, a report from Cermakian and colleagues also highlights that Rev-erbbeta can regulate circadian transcription of the Bmal1 gene [Guillaumond et al., 2005].
###end p 13
###begin title 14
Rev-erbs and inflammation
###end title 14
###begin p 15
###xml 117 136 114 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r115" ref-type="bibr">Barish et al., 2005</xref>
###xml 529 548 518 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r60" ref-type="bibr">Migita et al., 2004</xref>
###xml 732 753 705 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r117" ref-type="bibr">Delerive et al., 2001</xref>
###xml 972 997 930 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r40" ref-type="bibr">Ramakrishnan et al., 2005</xref>
###xml 1282 1304 1236 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r79" ref-type="bibr">Wallenius et al., 2002</xref>
###xml 1383 1406 1337 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r34" ref-type="bibr">McPherron and Lee, 2002</xref>
###xml 598 603 <span type="species:ncbi:9606">human</span>
Lipopolysaccharide induced activation of bone marrow derived macrophages induces biphasic regulation of Rev-erbbeta [Barish et al., 2005]. Recent studies have shown that inflammatory cytokines play crucial roles in endothelial and smooth muscle cell responses in diseases associated with the vasculature. Vascular smooth muscle cells over-expressing Rev-erbalpha induced NF-kappaB mediated trans-activation (and p65 translocation). In addition, increased expression of the pro-inflammatory cytokines IL-6 and COX-2 was observed [Migita et al., 2004]. Concordantly, ectopic expression of RORalphain human smooth muscle cells inhibits TNFalpha mediated induction of IL-6, IL-8, and COX-2 expression through induction of IkappaBalpha [Delerive et al., 2001]. The attenuation of Rev-erbbeta expression/function in skeletal muscle cells has been reported to induce IL-6 mRNA expression. Paradoxically, this was associated with increased expression of RORalpha and IkappaBalpha[Ramakrishnan et al., 2005]. IL-6 is an exercise induced myokine that induces lipolysis in adipose tissue, and suppresses TNFalpha production. The increased expression of IL-6 is consistent with decreased myostatin expression. For example, it has been reported that IL-6 deficiency leads to late-onset obesity [Wallenius et al., 2002], whereas myostatin deficiency leads to the reduced accumulation of body fat [McPherron and Lee, 2002]. Therefore, the inverse correlation between IL-6 and myostatin expression after attenuation of Rev-erbbeta expression is in concordance with the reported phenotypic effects of these proteins. The studies above highlight the emerging role of Rev-erbs in the inflammation cascade.
###end p 15
###begin title 16
Concluding remarks and future directions
###end title 16
###begin p 17
###xml 312 333 312 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r107" ref-type="bibr">Reinking et al., 2005</xref>
###xml 672 691 668 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r119" ref-type="bibr">Schild et al., 2006</xref>
###xml 903 911 895 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3</xref>
###xml 1019 1038 1011 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r110" ref-type="bibr">Pardee et al., 2004</xref>
###xml 1182 1201 1167 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r105" ref-type="bibr">Kallen et al., 2004</xref>
###xml 1203 1222 1188 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r106" ref-type="bibr">Kallen et al., 2002</xref>
###xml 1224 1249 1209 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="r104" ref-type="bibr">Stehlin-Gaon et al., 2003</xref>
###xml 386 396 <span type="species:ncbi:7227">Drosophila</span>
###xml 411 416 <span type="species:ncbi:9606">human</span>
###xml 858 868 <span type="species:ncbi:7227">Drosophila</span>
###xml 883 888 <span type="species:ncbi:9606">human</span>
Molecular modeling suggests the cavities in the LBDs of the NR1D subgroup are occupied by bulky side chains. This indicates that pharmacological manipulation of this orphan NR subgroup by agonists and antagonists in the near future may present technical challenges. However, a recent report from Reinking et al [Reinking et al., 2005] has shown that the ligand binding pocket of E75, a Drosophila orthologue of human Rev-erbalpha is tightly bound by heme. In recent years, various heme containing molecules have been identified to regulate lipid homeostasis. For example, heme containing neuronal nitric oxide synthase regulates genes involved in the lipogenesis pathway [Schild et al., 2006]. Curiously, Reinking and colleagues also identified E75 as a potential gas sensor and that CO or NO bind to E75 to interfere with E75 mediated repression of DHR3, a Drosophila orthologue of human RORalpha, see Figure 3). Moreover, heme, NO and CO are important regulatory molecules in mammalian circadian clocks (reviewed in [Pardee et al., 2004]). Recently, cholesterol/cholesterol sulphate and all-trans retinoic acid have been identified as RORalpha and RORbeta agonists, respectively [Kallen et al., 2004; Kallen et al., 2002; Stehlin-Gaon et al., 2003]. In summary, these studies suggest that identification of novel synthetic small molecule regulators for the NR1D subgroup by contemporary chemistry in the near future is possible.
###end p 17
###begin p 18
Further insights into the function of the NR1D subgroup in the short term will require targeted genetic analysis of both Rev-erbalpha and beta in specific tissues and organs. Cell specific attenuation of the NR1D subgroup (by Cre-Lox and/or transgenic techniques) in the major mass tissues (including skeletal muscle, liver and adipose tissue) will provide novel insights into the physiological role of these orphan NRs in metabolism.
###end p 18
###begin p 19
The NR1D subgroups are transcriptional silencers, and identification of target genes is certainly an area requiring additional study. Current studies indicate Rev-erb signaling impacts on RORalpha and PPARalpha-mediated control of inflammation and metabolism. Furthermore, it is increasingly apparent that Rev-erbalpha is an integral component of complex transcriptional feedback loops that are involved in circadian control. Complete elucidation of the pathophysiologically relevant targets of the Rev-erbs and the crosstalk with other NR signaling pathways in a cell/organ specific context will provide unique insights into the links between metabolism, inflammation and the circadian cycle in homeostasis.
###end p 19
###begin p 20
We apologize to those authors whose work was not cited in the pursuit of brevity. We thank Michael Pearen for his help in preparing Figure 1. SR holds an University of Queensland Postgraduate Scholarship. GEOM is a Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC), and this study was supported by an NHMRC project grant. 
###end p 20
###begin title 21
Abbreviations
###end title 21
###begin p 22
 apolipoprotein A1
###end p 22
###begin p 23
 apolipoprotein CIII
###end p 23
###begin p 24
 apolipoprotein E
###end p 24
###begin p 25
 Brain and Muscle Arnt-like protein-1 
###end p 25
###begin p 26
 base pair(s)
###end p 26
###begin p 27
 carbon-monoxide
###end p 27
###begin p 28
 cyclooxygenase 2
###end p 28
###begin p 29
 direct repeat 2
###end p 29
###begin p 30
 fatty acid binding protein
###end p 30
###begin p 31
 fatty acid translocase
###end p 31
###begin p 32
 high density lipoprotein
###end p 32
###begin p 33
 Interleukin-6
###end p 33
###begin p 34
 Inhibitor of NF;
###end p 34
###begin p 35
 ligand binding domain
###end p 35
###begin p 36
 nuclear factor kappaB
###end p 36
###begin p 37
 nitric-oxide
###end p 37
###begin p 38
 nuclear receptor
###end p 38
###begin p 39
 peroxisome proliferators-activated receptor
###end p 39
###begin p 40
 RAR-related orphan receptor
###end p 40
###begin p 41
 transforming growth factor beta
###end p 41
###begin p 42
 tumor necrosis factor alpha
###end p 42
###begin p 43
 very low density lipoprotein
###end p 43
###begin article-title 44
###xml 61 66 <span type="species:ncbi:9606">human</span>
A functional Rev-erb alpha responsive element located in the human Rev-erb alpha promoter mediates a repressing activity
###end article-title 44
###begin article-title 45
A serum shock induces circadian gene expression in mammalian tissue culture cells
###end article-title 45
###begin article-title 46
A Nuclear Receptor Atlas: macrophage activation
###end article-title 46
###begin article-title 47
Transcriptional repression by the orphan steroid receptor RVR/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis
###end article-title 47
###begin article-title 48
Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation
###end article-title 48
###begin article-title 49
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Increased cell death and delayed development in the cerebellum of mice lacking the rev-erbA(alpha) orphan receptor
###end article-title 49
###begin article-title 50
###xml 59 64 <span type="species:ncbi:9606">human</span>
Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter
###end article-title 50
###begin article-title 51
###xml 43 52 <span type="species:ncbi:7955">zebrafish</span>
An inherited functional circadian clock in zebrafish embryos
###end article-title 51
###begin article-title 52
Identification of Reverb(alpha) as a novel ROR(alpha) target gene
###end article-title 52
###begin article-title 53
The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response
###end article-title 53
###begin article-title 54
Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family
###end article-title 54
###begin article-title 55
A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb
###end article-title 55
###begin article-title 56
A rhythmic Ror
###end article-title 56
###begin article-title 57
The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation
###end article-title 57
###begin article-title 58
Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors
###end article-title 58
###begin article-title 59
A Nuclear Receptor Atlas: 3T3-L1 adipogenesis
###end article-title 59
###begin article-title 60
###xml 18 23 <span type="species:ncbi:9606">human</span>
Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element
###end article-title 60
###begin article-title 61
Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors
###end article-title 61
###begin article-title 62
Relevance of blood pressure variation in the circadian onset of cardiovascular events
###end article-title 62
###begin article-title 63
Role of myostatin in metabolism
###end article-title 63
###begin article-title 64
Principles for modulation of the nuclear receptor superfamily
###end article-title 64
###begin article-title 65
Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors
###end article-title 65
###begin article-title 66
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Morning rise in blood pressure is a predictor of left ventricular hypertrophy in treated hypertensive patients
###end article-title 66
###begin article-title 67
###xml 25 30 <span type="species:ncbi:9606">human</span>
Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A
###end article-title 67
###begin article-title 68
X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha
###end article-title 68
###begin article-title 69
Orphan nuclear hormone receptor RevErbalpha modulates expression from the promoter of the hydratase-dehydrogenase gene by inhibiting peroxisome proliferator-activated receptor alpha-dependent transactivation
###end article-title 69
###begin article-title 70
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues
###end article-title 70
###begin article-title 71

###end article-title 71
###begin article-title 72
The role of the orphan nuclear receptor Rev-Erb alpha in adipocyte differentiation and function
###end article-title 72
###begin article-title 73
###xml 103 106 <span type="species:ncbi:10116">rat</span>
A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbA alpha transcriptional unit
###end article-title 73
###begin article-title 74
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Suppression of body fat accumulation in myostatin-deficient mice
###end article-title 74
###begin article-title 75
Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cells
###end article-title 75
###begin article-title 76
Nuclear hormone receptors, metabolism, and aging: what goes around comes around.Transcription factors link lipid metabolism and aging-related processes
###end article-title 76
###begin article-title 77
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Aberrant expression of myosin isoforms in skeletal muscles from mice lacking the rev-erbAalpha orphan receptor gene
###end article-title 77
###begin article-title 78
The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator
###end article-title 78
###begin article-title 79
Rev-erbbeta regulates the expression of genes involved in lipid absorption in skeletal muscle cells: evidence for cross-talk between orphan nuclear receptors and myokines
###end article-title 79
###begin article-title 80
Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription
###end article-title 80
###begin article-title 81
###xml 30 35 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of human Rev-erbalpha gene expression by the orphan nuclear receptor retinoic acid-related orphan receptor alpha
###end article-title 81
###begin article-title 82
###xml 4 14 <span type="species:ncbi:7227">Drosophila</span>
The Drosophila nuclear receptor e75 contains heme and is gas responsive
###end article-title 82
###begin article-title 83
Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains
###end article-title 83
###begin article-title 84
Identification of RVR, a novel orphan nuclear receptor that acts as a negative transcriptional regulator
###end article-title 84
###begin article-title 85
A functional genomics strategy reveals Rora as a component of the mammalian circadian clock
###end article-title 85
###begin article-title 86
Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolism
###end article-title 86
###begin article-title 87
All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta
###end article-title 87
###begin article-title 88
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
Physical and inflammatory stressors elevate circadian clock gene mPer1 mRNA levels in the paraventricular nucleus of the mouse
###end article-title 88
###begin article-title 89
Circadian and glucocorticoid regulation of Rev-erbalpha expression in liver
###end article-title 89
###begin article-title 90
The orphan receptor Rev-erbalpha gene is a target of the circadian clock pacemaker
###end article-title 90
###begin article-title 91
Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines
###end article-title 91
###begin article-title 92
The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates
###end article-title 92
###begin article-title 93
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Interleukin-6-deficient mice develop mature-onset obesity
###end article-title 93
###begin article-title 94
Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock
###end article-title 94
###begin title 95
Figures and Tables
###end title 95
###begin title 96
Target genes of the NR1D subgroup.
###end title 96
###begin p 97
"Rev-erbs" regulate gene expression events in various species and tissues. Genes listed include primary and secondary targets that have been documented in the literature. 
###end p 97
###begin title 98
Cross-talk between Rev-erbalpha and RORalpha signaling in circadian gene regulation.
###end title 98
###begin p 99
Rev-erbalpha and RORalpha mutually regulate circadian Clock genes. Dysregulation in these pathways leads to chronic disease state such as metabolic syndrome.
###end p 99
###begin title 100
A speculative model for ligand-dependent Rev-erbalpha modulation in mammals.
###end title 100
###begin p 101
###xml 5 15 <span type="species:ncbi:7227">Drosophila</span>
Like Drosophila, endogenous molecules such as heme and diatomic gases could possibly bind to Rev-erbalpha and activate/modulate its ability to trans-repress RORalpha and other gene expression events.
###end p 101

